1. Home
  2. FSEA vs NEPH Comparison

FSEA vs NEPH Comparison

Compare FSEA & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Seacoast Bancorp Inc.

FSEA

First Seacoast Bancorp Inc.

HOLD

Current Price

$12.90

Market Cap

56.1M

Sector

Finance

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$4.66

Market Cap

60.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSEA
NEPH
Founded
1890
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.1M
60.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
FSEA
NEPH
Price
$12.90
$4.66
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
5.6K
68.8K
Earning Date
11-14-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
$14,753,000.00
$17,930,000.00
Revenue This Year
N/A
$33.32
Revenue Next Year
N/A
$12.27
P/E Ratio
N/A
$34.93
Revenue Growth
29.53
32.36
52 Week Low
$9.53
$1.39
52 Week High
$14.47
$6.42

Technical Indicators

Market Signals
Indicator
FSEA
NEPH
Relative Strength Index (RSI) 60.23 43.05
Support Level $12.12 $4.80
Resistance Level $14.47 $5.34
Average True Range (ATR) 0.53 0.41
MACD 0.08 -0.05
Stochastic Oscillator 32.04 13.14

Price Performance

Historical Comparison
FSEA
NEPH

About FSEA First Seacoast Bancorp Inc.

First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: